08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
A major source of contention, amongst the workers’ compensation division, is whether the insurance ...
Read More >
On August 12, 2019, New York Governor Andrew Cuomo signed into law a sweeping reform of sexual haras...
Read More >
A bill that would have brought the state’s tipping regulations in line with federal regulations was...
Read More >
The U.S. Renewable Energy Industry, including its construction market, like every sector of the econ...
Read More >
FASB has issued an Invitation to Comment, or ITC, as part of FASB’s project on certain identifiabl...
Read More >
The National Labor Relations Board (NLRB) announced today its intent to publish a proposed “Electio...
Read More >